fanta.bio Sample: CNhs11084
15075 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| HIF1A SRX11007095 | HK-2 Kidney | 1630 / 9622 (16.9%) | 652 / 96220 (0.7%) | −324.0 | −324.0 | 25.00 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 804 / 9622 (8.4%) | 326 / 96220 (0.3%) | −324.0 | −324.0 | 24.66 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1149 / 9622 (11.9%) | 534 / 96220 (0.6%) | −324.0 | −324.0 | 21.52 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1020 / 9622 (10.6%) | 587 / 96220 (0.6%) | −324.0 | −324.0 | 17.38 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1432 / 9622 (14.9%) | 875 / 96220 (0.9%) | −324.0 | −324.0 | 16.37 |
| SCML2 SRX644728 | 293 Kidney | 878 / 9622 (9.1%) | 537 / 96220 (0.6%) | −324.0 | −324.0 | 16.35 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1368 / 9622 (14.2%) | 849 / 96220 (0.9%) | −324.0 | −324.0 | 16.11 |
| BRD4 SRX9419935 | BT-474 Breast | 2289 / 9622 (23.8%) | 1891 / 96220 (2.0%) | −324.0 | −324.0 | 12.10 |
| FOXP1 SRX736067 | LNCAP Prostate | 1041 / 9622 (10.8%) | 874 / 96220 (0.9%) | −324.0 | −324.0 | 11.91 |
| BRD4 SRX9419937 | BT-474 Breast | 2263 / 9622 (23.5%) | 1925 / 96220 (2.0%) | −324.0 | −324.0 | 11.76 |
| MED1 SRX9419945 | BT-474 Breast | 2237 / 9622 (23.2%) | 1947 / 96220 (2.0%) | −324.0 | −324.0 | 11.49 |
| MED1 SRX9419944 | BT-474 Breast | 2165 / 9622 (22.5%) | 1911 / 96220 (2.0%) | −324.0 | −324.0 | 11.33 |
| BRD4 SRX9419936 | BT-474 Breast | 2264 / 9622 (23.5%) | 2017 / 96220 (2.1%) | −324.0 | −324.0 | 11.22 |
| BRD4 SRX9419938 | BT-474 Breast | 2219 / 9622 (23.1%) | 2011 / 96220 (2.1%) | −324.0 | −324.0 | 11.03 |
| MED1 SRX9419946 | BT-474 Breast | 2240 / 9622 (23.3%) | 2034 / 96220 (2.1%) | −324.0 | −324.0 | 11.01 |
| MED1 SRX9419947 | BT-474 Breast | 2178 / 9622 (22.6%) | 1978 / 96220 (2.1%) | −324.0 | −324.0 | 11.01 |
| EZH2 SRX2146136 | LNCAP Prostate | 4483 / 9622 (46.6%) | 5346 / 96220 (5.6%) | −324.0 | −324.0 | 8.39 |
| BRD4 SRX736201 | 90-8TL Neural | 3389 / 9622 (35.2%) | 4284 / 96220 (4.5%) | −324.0 | −324.0 | 7.91 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1013 / 9622 (10.5%) | 1760 / 96220 (1.8%) | −324.0 | −324.0 | 5.76 |
| MYH11 SRX265221 | ME-1 Blood | 551 / 9622 (5.7%) | 414 / 96220 (0.4%) | −311.7 | −308.5 | 13.31 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1177 / 9622 (12.2%) | 2956 / 96220 (3.1%) | −294.5 | −291.3 | 3.98 |
| RUNX1 SRX2513054 | 293 Kidney | 2339 / 9622 (24.3%) | 10255 / 96220 (10.7%) | −278.7 | −275.6 | 2.28 |
| TP53 SRX19538279 | Osteoblasts Bone | 385 / 9622 (4.0%) | 160 / 96220 (0.2%) | −268.5 | −265.4 | 24.06 |
| PBX4 SRX2731658 | PC-3 Prostate | 413 / 9622 (4.3%) | 14956 / 96220 (15.5%) | −252.1 | −248.9 | 0.28 |
| 5-mC SRX882970 | LNCAP Prostate | 2053 / 9622 (21.3%) | 8813 / 96220 (9.2%) | −249.9 | −246.8 | 2.33 |
| 5-mC SRX882968 | LNCAP Prostate | 2012 / 9622 (20.9%) | 8735 / 96220 (9.1%) | −238.9 | −235.8 | 2.30 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 901 / 9622 (9.4%) | 2177 / 96220 (2.3%) | −232.0 | −228.9 | 4.14 |
| HIF1A SRX20663235 | HK-2 Kidney | 349 / 9622 (3.6%) | 170 / 96220 (0.2%) | −231.6 | −228.6 | 20.53 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1503 / 9622 (15.6%) | 5613 / 96220 (5.8%) | −226.0 | −222.9 | 2.68 |
| TP53 SRX19538274 | U2OS Bone | 310 / 9622 (3.2%) | 119 / 96220 (0.1%) | −220.9 | −217.9 | 26.05 |
| TP53 SRX19538268 | U2OS Bone | 309 / 9622 (3.2%) | 119 / 96220 (0.1%) | −220.0 | −217.0 | 25.97 |
| TP53 SRX19538280 | Osteoblasts Bone | 304 / 9622 (3.2%) | 120 / 96220 (0.1%) | −215.0 | −211.9 | 25.33 |
| CIC SRX13262055 | Astrocytes Neural | 2075 / 9622 (21.6%) | 9701 / 96220 (10.1%) | −212.0 | −209.0 | 2.14 |
| AGO2 SRX4708039 | Hep G2 Liver | 1278 / 9622 (13.3%) | 4450 / 96220 (4.6%) | −211.7 | −208.7 | 2.87 |
| TP53 SRX19538276 | U2OS Bone | 303 / 9622 (3.1%) | 126 / 96220 (0.1%) | −211.1 | −208.1 | 24.05 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 487 / 9622 (5.1%) | 612 / 96220 (0.6%) | −210.1 | −207.1 | 7.96 |
| 5-mC SRX882965 | LNCAP Prostate | 1645 / 9622 (17.1%) | 6785 / 96220 (7.1%) | −210.0 | −207.0 | 2.42 |
| TP53 SRX19538273 | U2OS Bone | 285 / 9622 (3.0%) | 97 / 96220 (0.1%) | −209.7 | −206.8 | 29.38 |
| FOS SRX150477 | MCF 10A Breast | 264 / 9622 (2.7%) | 11081 / 96220 (11.5%) | −206.4 | −203.5 | 0.24 |
| FOS SRX150478 | MCF 10A Breast | 291 / 9622 (3.0%) | 11412 / 96220 (11.9%) | −201.2 | −198.2 | 0.25 |
| IRF3 SRX11453858 | Hep G2 Liver | 245 / 9622 (2.5%) | 56 / 96220 (0.1%) | −197.1 | −194.2 | 43.75 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1009 / 9622 (10.5%) | 3105 / 96220 (3.2%) | −196.3 | −193.4 | 3.25 |
| TP53 SRX19538281 | Osteoblasts Bone | 312 / 9622 (3.2%) | 179 / 96220 (0.2%) | −195.6 | −192.7 | 17.43 |
| TP53 SRX19538269 | U2OS Bone | 340 / 9622 (3.5%) | 253 / 96220 (0.3%) | −192.3 | −189.4 | 13.44 |
| TP53 SRX19538275 | U2OS Bone | 277 / 9622 (2.9%) | 117 / 96220 (0.1%) | −192.0 | −189.2 | 23.68 |
| TP53 SRX19538267 | U2OS Bone | 263 / 9622 (2.7%) | 107 / 96220 (0.1%) | −184.3 | −181.5 | 24.58 |
| YAP1 SRX757325 | H2052 Lung | 337 / 9622 (3.5%) | 11598 / 96220 (12.1%) | −181.2 | −178.4 | 0.29 |
| FOS SRX4192880 | MCF 10A Breast | 193 / 9622 (2.0%) | 9048 / 96220 (9.4%) | −180.6 | −177.7 | 0.21 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 425 / 9622 (4.4%) | 549 / 96220 (0.6%) | −179.9 | −177.1 | 7.74 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 282 / 9622 (2.9%) | 10606 / 96220 (11.0%) | −179.1 | −176.3 | 0.27 |
| SREBF2 SRX5359048 | HCC70 Breast | 1189 / 9622 (12.4%) | 4386 / 96220 (4.6%) | −179.1 | −176.3 | 2.71 |
| TRP47 SRX4548329 | THP-1 Blood | 1729 / 9622 (18.0%) | 7974 / 96220 (8.3%) | −177.5 | −174.7 | 2.17 |
| KAT6A SRX20971022 | Fibroblasts Others | 217 / 9622 (2.3%) | 49 / 96220 (0.1%) | −174.9 | −172.1 | 44.29 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1195 / 9622 (12.4%) | 4513 / 96220 (4.7%) | −173.2 | −170.4 | 2.65 |
| FOXA1 SRX4815198 | MCF-7 Breast | 491 / 9622 (5.1%) | 13713 / 96220 (14.3%) | −171.1 | −168.3 | 0.36 |
| TP53 SRX19538270 | U2OS Bone | 311 / 9622 (3.2%) | 247 / 96220 (0.3%) | −170.9 | −168.1 | 12.59 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1296 / 9622 (13.5%) | 5197 / 96220 (5.4%) | −170.4 | −167.6 | 2.49 |
| RUNX1 SRX2014504 | Jurkat Blood | 1613 / 9622 (16.8%) | 7328 / 96220 (7.6%) | −169.7 | −166.9 | 2.20 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1316 / 9622 (13.7%) | 5342 / 96220 (5.6%) | −169.4 | −166.7 | 2.46 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1245 / 9622 (12.9%) | 4900 / 96220 (5.1%) | −168.6 | −165.9 | 2.54 |
| IRF3 SRX11453861 | Hep G2 Liver | 217 / 9622 (2.3%) | 59 / 96220 (0.1%) | −168.4 | −165.6 | 36.78 |
| YAP1 SRX757326 | H2052 Lung | 289 / 9622 (3.0%) | 10372 / 96220 (10.8%) | −167.3 | −164.6 | 0.28 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 363 / 9622 (3.8%) | 416 / 96220 (0.4%) | −165.2 | −162.4 | 8.73 |
| FOXA1 SRX176862 | MCF-7 Breast | 158 / 9622 (1.6%) | 7888 / 96220 (8.2%) | −163.2 | −160.5 | 0.20 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1119 / 9622 (11.6%) | 4209 / 96220 (4.4%) | −162.6 | −159.9 | 2.66 |
| FOXA1 SRX4815197 | MCF-7 Breast | 356 / 9622 (3.7%) | 11255 / 96220 (11.7%) | −160.1 | −157.4 | 0.32 |
| MECOM SRX23677896 | HNT-34 Blood | 1405 / 9622 (14.6%) | 6166 / 96220 (6.4%) | −156.7 | −154.0 | 2.28 |
| TP53 SRX19538282 | Osteoblasts Bone | 268 / 9622 (2.8%) | 188 / 96220 (0.2%) | −155.3 | −152.7 | 14.26 |
| BMI1 SRX7196721 | SF8628 Neural | 1152 / 9622 (12.0%) | 4533 / 96220 (4.7%) | −155.3 | −152.6 | 2.54 |
| MECOM SRX23677885 | HNT-34 Blood | 1176 / 9622 (12.2%) | 4691 / 96220 (4.9%) | −154.9 | −152.3 | 2.51 |
| FOS SRX150476 | MCF 10A Breast | 234 / 9622 (2.4%) | 9045 / 96220 (9.4%) | −154.7 | −152.1 | 0.26 |
| MECOM SRX23677897 | HNT-34 Blood | 1356 / 9622 (14.1%) | 5878 / 96220 (6.1%) | −154.5 | −151.8 | 2.31 |
| PTEN SRX5416007 | SMMC-7721 Liver | 1199 / 9622 (12.5%) | 4850 / 96220 (5.0%) | −154.3 | −151.6 | 2.47 |
| MECOM SRX23677884 | HNT-34 Blood | 1161 / 9622 (12.1%) | 4636 / 96220 (4.8%) | −152.5 | −149.8 | 2.50 |
| FOS SRX150517 | MCF 10A Breast | 237 / 9622 (2.5%) | 9028 / 96220 (9.4%) | −152.4 | −149.8 | 0.26 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1057 / 9622 (11.0%) | 4000 / 96220 (4.2%) | −151.5 | −148.9 | 2.64 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 395 / 9622 (4.1%) | 593 / 96220 (0.6%) | −151.0 | −148.4 | 6.66 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 1189 / 9622 (12.4%) | 4853 / 96220 (5.0%) | −150.4 | −147.8 | 2.45 |
| FOXA1 SRX3931044 | MCF-7 Breast | 329 / 9622 (3.4%) | 10377 / 96220 (10.8%) | −146.3 | −143.7 | 0.32 |
| FOXA1 SRX1161177 | MCF-7 Breast | 123 / 9622 (1.3%) | 6719 / 96220 (7.0%) | −146.2 | −143.6 | 0.18 |
| FOXA1 SRX176863 | MCF-7 Breast | 163 / 9622 (1.7%) | 7479 / 96220 (7.8%) | −145.4 | −142.8 | 0.22 |
| BRD4 SRX736204 | 90-8TL Neural | 628 / 9622 (6.5%) | 1657 / 96220 (1.7%) | −145.2 | −142.6 | 3.79 |
| CDYL2 SRX8321653 | MCF-7 Breast | 1194 / 9622 (12.4%) | 4979 / 96220 (5.2%) | −145.2 | −142.6 | 2.40 |
| MITF SRX1555436 | 501A Epidermis | 1274 / 9622 (13.2%) | 5519 / 96220 (5.7%) | −144.6 | −142.0 | 2.31 |
| TP53 SRX19538271 | U2OS Bone | 421 / 9622 (4.4%) | 733 / 96220 (0.8%) | −144.0 | −141.4 | 5.74 |
| Epitope tags SRX10549776 | K-562 Blood | 872 / 9622 (9.1%) | 3019 / 96220 (3.1%) | −142.5 | −139.9 | 2.89 |
| FOXA1 SRX371482 | MCF-7 Breast | 209 / 9622 (2.2%) | 8207 / 96220 (8.5%) | −141.6 | −139.0 | 0.25 |
| FOXA1 SRX371483 | MCF-7 Breast | 154 / 9622 (1.6%) | 7185 / 96220 (7.5%) | −141.1 | −138.5 | 0.21 |
| GATA3 SRX190239 | MCF-7 Breast | 210 / 9622 (2.2%) | 8193 / 96220 (8.5%) | −140.6 | −138.0 | 0.26 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 343 / 9622 (3.6%) | 465 / 96220 (0.5%) | −140.5 | −138.0 | 7.38 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1125 / 9622 (11.7%) | 4615 / 96220 (4.8%) | −140.4 | −137.8 | 2.44 |
| Epitope tags SRX2867680 | 293 Kidney | 1339 / 9622 (13.9%) | 6041 / 96220 (6.3%) | −140.3 | −137.8 | 2.22 |
| JUNB SRX8488088 | SUM 229PE Breast | 300 / 9622 (3.1%) | 9675 / 96220 (10.1%) | −139.1 | −136.5 | 0.31 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 176 / 9622 (1.8%) | 7457 / 96220 (7.7%) | −136.4 | −133.9 | 0.24 |
| ESR1 SRX371469 | MCF-7 Breast | 143 / 9622 (1.5%) | 6838 / 96220 (7.1%) | −136.4 | −133.9 | 0.21 |
| FOS SRX4192879 | MCF 10A Breast | 156 / 9622 (1.6%) | 7083 / 96220 (7.4%) | −136.4 | −133.8 | 0.22 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 230 / 9622 (2.4%) | 153 / 96220 (0.2%) | −136.2 | −133.7 | 15.03 |
| ESR1 SRX371478 | MCF-7 Breast | 189 / 9622 (2.0%) | 7677 / 96220 (8.0%) | −135.9 | −133.4 | 0.25 |
| ESR1 SRX7624157 | MCF-7 Breast | 432 / 9622 (4.5%) | 11627 / 96220 (12.1%) | −135.6 | −133.1 | 0.37 |
| FOXA1 SRX371481 | MCF-7 Breast | 149 / 9622 (1.5%) | 6919 / 96220 (7.2%) | −135.2 | −132.7 | 0.22 |
| GATA3 SRX176864 | MCF-7 Breast | 85 / 9622 (0.9%) | 5610 / 96220 (5.8%) | −134.8 | −132.2 | 0.15 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 1205 / 9622 (12.5%) | 5292 / 96220 (5.5%) | −132.5 | −130.0 | 2.28 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 271 / 9622 (2.8%) | 8961 / 96220 (9.3%) | −131.8 | −129.3 | 0.30 |
| ESR1 SRX4367193 | MCF-7 Breast | 561 / 9622 (5.8%) | 13358 / 96220 (13.9%) | −131.2 | −128.7 | 0.42 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 1302 / 9622 (13.5%) | 5980 / 96220 (6.2%) | −131.0 | −128.5 | 2.18 |
| ESR1 SRX7624156 | MCF-7 Breast | 257 / 9622 (2.7%) | 8694 / 96220 (9.0%) | −130.7 | −128.2 | 0.30 |
| AGO2 SRX6783958 | Hep G2 Liver | 785 / 9622 (8.2%) | 2680 / 96220 (2.8%) | −130.6 | −128.1 | 2.93 |
| AGO2 SRX6783957 | Hep G2 Liver | 782 / 9622 (8.1%) | 2664 / 96220 (2.8%) | −130.4 | −127.9 | 2.94 |
| TLE3 SRX4815191 | MCF-7 Breast | 136 / 9622 (1.4%) | 6522 / 96220 (6.8%) | −130.1 | −127.6 | 0.21 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 225 / 9622 (2.3%) | 8127 / 96220 (8.4%) | −129.9 | −127.4 | 0.28 |
| ESR1 SRX20282961 | MCF-7 Breast | 198 / 9622 (2.1%) | 7644 / 96220 (7.9%) | −129.6 | −127.1 | 0.26 |
| ERG SRX063922 | K-562 Blood | 1010 / 9622 (10.5%) | 4068 / 96220 (4.2%) | −129.5 | −127.1 | 2.48 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 409 / 9622 (4.3%) | 782 / 96220 (0.8%) | −129.4 | −126.9 | 5.23 |
| RORC SRX5359052 | HCC70 Breast | 846 / 9622 (8.8%) | 3059 / 96220 (3.2%) | −129.1 | −126.7 | 2.77 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 369 / 9622 (3.8%) | 10438 / 96220 (10.8%) | −129.0 | −126.6 | 0.35 |
| FOXA1 SRX1161176 | MCF-7 Breast | 136 / 9622 (1.4%) | 6488 / 96220 (6.7%) | −129.0 | −126.5 | 0.21 |
| ESR1 SRX176860 | MCF-7 Breast | 266 / 9622 (2.8%) | 8778 / 96220 (9.1%) | −128.6 | −126.2 | 0.30 |
| ESR1 SRX371479 | MCF-7 Breast | 130 / 9622 (1.4%) | 6347 / 96220 (6.6%) | −128.1 | −125.7 | 0.20 |
| FOXA1 SRX1161173 | MCF-7 Breast | 110 / 9622 (1.1%) | 5935 / 96220 (6.2%) | −127.5 | −125.0 | 0.19 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 267 / 9622 (2.8%) | 8745 / 96220 (9.1%) | −127.0 | −124.5 | 0.31 |
| TET2 SRX2014505 | Jurkat Blood | 1618 / 9622 (16.8%) | 8352 / 96220 (8.7%) | −126.3 | −123.9 | 1.94 |
| RORC SRX5359053 | HCC70 Breast | 813 / 9622 (8.4%) | 2911 / 96220 (3.0%) | −125.8 | −123.3 | 2.79 |
| ESR1 SRX194569 | MCF-7 Breast | 159 / 9622 (1.7%) | 6818 / 96220 (7.1%) | −125.5 | −123.0 | 0.23 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 184 / 9622 (1.9%) | 7271 / 96220 (7.6%) | −125.4 | −123.0 | 0.25 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 206 / 9622 (2.1%) | 7633 / 96220 (7.9%) | −124.5 | −122.1 | 0.27 |
| AR SRX10820653 | LNCAP Prostate | 208 / 9622 (2.2%) | 141 / 96220 (0.1%) | −122.3 | −119.9 | 14.75 |
| JUN SRX4192884 | MCF 10A Breast | 113 / 9622 (1.2%) | 5835 / 96220 (6.1%) | −121.8 | −119.4 | 0.19 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 191 / 9622 (2.0%) | 7282 / 96220 (7.6%) | −121.7 | −119.3 | 0.26 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 714 / 9622 (7.4%) | 2396 / 96220 (2.5%) | −121.4 | −119.0 | 2.98 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1040 / 9622 (10.8%) | 4411 / 96220 (4.6%) | −121.3 | −118.9 | 2.36 |
| GATA3 SRX5057632 | MCF-7 Breast | 82 / 9622 (0.9%) | 5177 / 96220 (5.4%) | −121.2 | −118.8 | 0.16 |
| ESR1 SRX371467 | MCF-7 Breast | 167 / 9622 (1.7%) | 6841 / 96220 (7.1%) | −121.2 | −118.8 | 0.24 |
| AR SRX1067067 | LHSAR Prostate | 289 / 9622 (3.0%) | 8903 / 96220 (9.3%) | −120.9 | −118.5 | 0.32 |
| ESR1 SRX194572 | MCF-7 Breast | 83 / 9622 (0.9%) | 5184 / 96220 (5.4%) | −120.7 | −118.4 | 0.16 |
| FOXA1 SRX1161175 | MCF-7 Breast | 108 / 9622 (1.1%) | 5691 / 96220 (5.9%) | −120.4 | −118.0 | 0.19 |
| JUNB SRX4192882 | MCF 10A Breast | 104 / 9622 (1.1%) | 5606 / 96220 (5.8%) | −120.2 | −117.8 | 0.19 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 608 / 9622 (6.3%) | 13588 / 96220 (14.1%) | −119.6 | −117.3 | 0.45 |
| ESR1 SRX20282960 | MCF-7 Breast | 189 / 9622 (2.0%) | 7160 / 96220 (7.4%) | −118.9 | −116.6 | 0.26 |
| MethylCap SRX014767 | NB-4 Blood | 1070 / 9622 (11.1%) | 4660 / 96220 (4.8%) | −118.5 | −116.2 | 2.30 |
| ESR1 SRX371476 | MCF-7 Breast | 108 / 9622 (1.1%) | 5630 / 96220 (5.9%) | −118.1 | −115.7 | 0.19 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 217 / 9622 (2.3%) | 7623 / 96220 (7.9%) | −118.1 | −115.7 | 0.28 |
| ERG SRX063921 | K-562 Blood | 939 / 9622 (9.8%) | 3825 / 96220 (4.0%) | −117.6 | −115.2 | 2.45 |
| ESR1 SRX20282939 | MCF-7 Breast | 192 / 9622 (2.0%) | 7157 / 96220 (7.4%) | −117.0 | −114.6 | 0.27 |
| AR SRX1067071 | LHSAR Prostate | 351 / 9622 (3.6%) | 9746 / 96220 (10.1%) | −116.9 | −114.5 | 0.36 |
| ESR1 SRX371471 | ZR-75-1 Breast | 182 / 9622 (1.9%) | 6971 / 96220 (7.2%) | −116.7 | −114.4 | 0.26 |
| ESR1 SRX371468 | MCF-7 Breast | 90 / 9622 (0.9%) | 5210 / 96220 (5.4%) | −116.3 | −113.9 | 0.17 |
| RAC1 SRX10365543 | MCF-7 Breast | 66 / 9622 (0.7%) | 4687 / 96220 (4.9%) | −116.2 | −113.8 | 0.14 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 139 / 9622 (1.4%) | 6164 / 96220 (6.4%) | −115.8 | −113.5 | 0.23 |
| JUNB SRX10119386 | MCF 10A Breast | 135 / 9622 (1.4%) | 6073 / 96220 (6.3%) | −115.4 | −113.1 | 0.22 |
| MECOM SRX23677890 | HNT-34 Blood | 1105 / 9622 (11.5%) | 4970 / 96220 (5.2%) | −114.8 | −112.5 | 2.22 |
| FOXA1 SRX1787653 | MCF-7 Breast | 122 / 9622 (1.3%) | 5806 / 96220 (6.0%) | −114.7 | −112.4 | 0.21 |
| ESR1 SRX371470 | ZR-75-1 Breast | 150 / 9622 (1.6%) | 6334 / 96220 (6.6%) | −114.7 | −112.4 | 0.24 |
| ESR1 SRX1531791 | MCF-7 Breast | 160 / 9622 (1.7%) | 6504 / 96220 (6.8%) | −114.3 | −112.0 | 0.25 |
| ESR1 SRX176861 | MCF-7 Breast | 297 / 9622 (3.1%) | 8801 / 96220 (9.1%) | −114.1 | −111.7 | 0.34 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 163 / 9622 (1.7%) | 6550 / 96220 (6.8%) | −114.0 | −111.7 | 0.25 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 124 / 9622 (1.3%) | 5785 / 96220 (6.0%) | −112.6 | −110.3 | 0.21 |
| FOXA1 SRX371480 | MCF-7 Breast | 106 / 9622 (1.1%) | 5433 / 96220 (5.6%) | −112.6 | −110.3 | 0.20 |
| FOXA1 SRX1161174 | MCF-7 Breast | 170 / 9622 (1.8%) | 6630 / 96220 (6.9%) | −112.5 | −110.2 | 0.26 |
| TP53 SRX19538272 | U2OS Bone | 352 / 9622 (3.7%) | 665 / 96220 (0.7%) | −112.4 | −110.1 | 5.29 |
| FOXA1 SRX100454 | T-47D Breast | 230 / 9622 (2.4%) | 7647 / 96220 (7.9%) | −112.0 | −109.7 | 0.30 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 165 / 9622 (1.7%) | 6512 / 96220 (6.8%) | −111.6 | −109.3 | 0.25 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 773 / 9622 (8.0%) | 2889 / 96220 (3.0%) | −111.5 | −109.2 | 2.68 |
| ZFX SRX7805372 | 293 Kidney | 953 / 9622 (9.9%) | 4026 / 96220 (4.2%) | −111.5 | −109.1 | 2.37 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 150 / 9622 (1.6%) | 6231 / 96220 (6.5%) | −111.3 | −109.0 | 0.24 |
| STAT5B SRX831881 | CD8+ T cells Blood | 177 / 9622 (1.8%) | 102 / 96220 (0.1%) | −110.8 | −108.5 | 17.35 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 264 / 9622 (2.7%) | 8161 / 96220 (8.5%) | −110.7 | −108.4 | 0.32 |
| FOXA1 SRX3923514 | MCF-7 Breast | 170 / 9622 (1.8%) | 6568 / 96220 (6.8%) | −110.6 | −108.3 | 0.26 |
| ESR1 SRX10365536 | MCF-7 Breast | 75 / 9622 (0.8%) | 4731 / 96220 (4.9%) | −110.4 | −108.2 | 0.16 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 182 / 9622 (1.9%) | 6774 / 96220 (7.0%) | −110.4 | −108.1 | 0.27 |
| ARID1A SRX5089376 | MCF-7 Breast | 140 / 9622 (1.5%) | 6020 / 96220 (6.3%) | −110.4 | −108.1 | 0.23 |
| CEBPB SRX150632 | HeLa Uterus | 417 / 9622 (4.3%) | 10501 / 96220 (10.9%) | −110.2 | −107.9 | 0.40 |
| FOXA1 SRX3931043 | MCF-7 Breast | 172 / 9622 (1.8%) | 6568 / 96220 (6.8%) | −109.4 | −107.2 | 0.26 |
| AR SRX1067068 | LHSAR Prostate | 208 / 9622 (2.2%) | 7194 / 96220 (7.5%) | −109.4 | −107.1 | 0.29 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 391 / 9622 (4.1%) | 856 / 96220 (0.9%) | −109.3 | −107.0 | 4.57 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 166 / 9622 (1.7%) | 83 / 96220 (0.1%) | −109.2 | −107.0 | 20.00 |
| ESR1 SRX20282972 | MCF-7 Breast | 197 / 9622 (2.0%) | 6984 / 96220 (7.3%) | −108.8 | −106.5 | 0.28 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 632 / 9622 (6.6%) | 13485 / 96220 (14.0%) | −108.7 | −106.4 | 0.47 |
| AR SRX1067066 | LHSAR Prostate | 406 / 9622 (4.2%) | 10260 / 96220 (10.7%) | −108.1 | −105.8 | 0.40 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 152 / 9622 (1.6%) | 6168 / 96220 (6.4%) | −108.0 | −105.7 | 0.25 |
| FOXA1 SRX11222441 | MCF-7 Breast | 123 / 9622 (1.3%) | 5624 / 96220 (5.8%) | −107.9 | −105.7 | 0.22 |
| SMARCA2 SRX8119677 | MeT-5A Others | 298 / 9622 (3.1%) | 8604 / 96220 (8.9%) | −107.8 | −105.5 | 0.35 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 156 / 9622 (1.6%) | 6232 / 96220 (6.5%) | −107.8 | −105.5 | 0.25 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 317 / 9622 (3.3%) | 8894 / 96220 (9.2%) | −107.6 | −105.3 | 0.36 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 152 / 9622 (1.6%) | 6154 / 96220 (6.4%) | −107.6 | −105.3 | 0.25 |
| VGLL1 SRX24602130 | BT-20 Breast | 181 / 9622 (1.9%) | 6665 / 96220 (6.9%) | −107.5 | −105.3 | 0.27 |
| JUNB SRX8488073 | SUM 229PE Breast | 355 / 9622 (3.7%) | 9468 / 96220 (9.8%) | −107.3 | −105.0 | 0.37 |
| GRHL3 SRX2582162 | NHEK Epidermis | 665 / 9622 (6.9%) | 2309 / 96220 (2.4%) | −107.2 | −105.0 | 2.88 |
| AR SRX10820651 | LNCAP Prostate | 209 / 9622 (2.2%) | 194 / 96220 (0.2%) | −106.6 | −104.3 | 10.77 |
| FOXA1 SRX11222437 | MCF-7 Breast | 116 / 9622 (1.2%) | 5449 / 96220 (5.7%) | −106.6 | −104.3 | 0.21 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 152 / 9622 (1.6%) | 6120 / 96220 (6.4%) | −106.5 | −104.3 | 0.25 |
| RAC1 SRX10365541 | MCF-7 Breast | 79 / 9622 (0.8%) | 4706 / 96220 (4.9%) | −106.4 | −104.2 | 0.17 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 163 / 9622 (1.7%) | 6313 / 96220 (6.6%) | −106.3 | −104.1 | 0.26 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 177 / 9622 (1.8%) | 6552 / 96220 (6.8%) | −106.1 | −103.8 | 0.27 |
| JUNB SRX8488089 | SUM 229PE Breast | 175 / 9622 (1.8%) | 6517 / 96220 (6.8%) | −106.0 | −103.8 | 0.27 |
| MECOM SRX23677891 | HNT-34 Blood | 1073 / 9622 (11.2%) | 4941 / 96220 (5.1%) | −105.9 | −103.7 | 2.17 |
| EP300 SRX150579 | HeLa Uterus | 101 / 9622 (1.0%) | 5127 / 96220 (5.3%) | −105.5 | −103.2 | 0.20 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 162 / 9622 (1.7%) | 6259 / 96220 (6.5%) | −105.2 | −103.0 | 0.26 |
| ESR1 SRX371477 | MCF-7 Breast | 71 / 9622 (0.7%) | 4495 / 96220 (4.7%) | −105.1 | −102.9 | 0.16 |
| FOXA1 SRX3931054 | MCF-7 Breast | 164 / 9622 (1.7%) | 6286 / 96220 (6.5%) | −104.9 | −102.7 | 0.26 |
| STAT3 SRX150479 | MCF 10A Breast | 155 / 9622 (1.6%) | 6122 / 96220 (6.4%) | −104.8 | −102.6 | 0.25 |
| STAT3 SRX150630 | MCF 10A Breast | 154 / 9622 (1.6%) | 6096 / 96220 (6.3%) | −104.6 | −102.4 | 0.25 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 236 / 9622 (2.5%) | 7496 / 96220 (7.8%) | −104.5 | −102.2 | 0.31 |
| CHD6 SRX17709200 | C4-2 Prostate | 942 / 9622 (9.8%) | 4096 / 96220 (4.3%) | −104.1 | −101.9 | 2.30 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 119 / 9622 (1.2%) | 5430 / 96220 (5.6%) | −104.0 | −101.7 | 0.22 |
| ESR1 SRX330070 | MCF-7 Breast | 74 / 9622 (0.8%) | 4525 / 96220 (4.7%) | −103.8 | −101.6 | 0.16 |
| ESR1 SRX20282946 | MCF-7 Breast | 93 / 9622 (1.0%) | 4915 / 96220 (5.1%) | −103.7 | −101.5 | 0.19 |
| Epitope tags SRX2255894 | 293 Kidney | 820 / 9622 (8.5%) | 3311 / 96220 (3.4%) | −103.7 | −101.5 | 2.48 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 194 / 9622 (2.0%) | 6769 / 96220 (7.0%) | −103.6 | −101.4 | 0.29 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 137 / 9622 (1.4%) | 5747 / 96220 (6.0%) | −103.3 | −101.1 | 0.24 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 412 / 9622 (4.3%) | 10162 / 96220 (10.6%) | −103.0 | −100.8 | 0.41 |
| Epitope tags SRX7276677 | 293 Kidney | 1565 / 9622 (16.3%) | 8594 / 96220 (8.9%) | −102.8 | −100.6 | 1.82 |
| SREBF2 SRX5359049 | HCC70 Breast | 725 / 9622 (7.5%) | 2744 / 96220 (2.9%) | −102.2 | −100.0 | 2.64 |
| SMARCA4 SRX5212366 | Mel270 Others | 252 / 9622 (2.6%) | 7680 / 96220 (8.0%) | −102.1 | −99.9 | 0.33 |
| FOXA1 SRX11222442 | MCF-7 Breast | 111 / 9622 (1.2%) | 5217 / 96220 (5.4%) | −101.9 | −99.7 | 0.21 |
| FOXA1 SRX1787652 | MCF-7 Breast | 96 / 9622 (1.0%) | 4915 / 96220 (5.1%) | −101.6 | −99.4 | 0.20 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 174 / 9622 (1.8%) | 6359 / 96220 (6.6%) | −101.6 | −99.4 | 0.27 |
| BRPF3 SRX796084 | RKO Digestive tract | 871 / 9622 (9.1%) | 3678 / 96220 (3.8%) | −101.5 | −99.3 | 2.37 |
| ESR1 SRX4367192 | MCF-7 Breast | 399 / 9622 (4.1%) | 9913 / 96220 (10.3%) | −101.5 | −99.3 | 0.40 |
| JUND SRX150408 | HeLa Uterus | 155 / 9622 (1.6%) | 6018 / 96220 (6.3%) | −101.4 | −99.2 | 0.26 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 75 / 9622 (0.8%) | 4470 / 96220 (4.6%) | −101.1 | −98.9 | 0.17 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 156 / 9622 (1.6%) | 6013 / 96220 (6.2%) | −100.7 | −98.6 | 0.26 |
| ESR1 SRX1012632 | MCF-7 Breast | 73 / 9622 (0.8%) | 4420 / 96220 (4.6%) | −100.7 | −98.5 | 0.17 |
| ESR1 SRX10365532 | MCF-7 Breast | 85 / 9622 (0.9%) | 4666 / 96220 (4.8%) | −100.6 | −98.4 | 0.18 |
| FOXA1 SRX028634 | MCF-7 Breast | 74 / 9622 (0.8%) | 4435 / 96220 (4.6%) | −100.6 | −98.4 | 0.17 |
| JUN SRX883584 | MDA-MB-231 Breast | 303 / 9622 (3.1%) | 8428 / 96220 (8.8%) | −100.4 | −98.2 | 0.36 |
| VGLL1 SRX18013277 | FULVR Breast | 61 / 9622 (0.6%) | 4145 / 96220 (4.3%) | −100.1 | −98.0 | 0.15 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 478 / 9622 (5.0%) | 1365 / 96220 (1.4%) | −100.1 | −98.0 | 3.50 |
| FOXA1 SRX1787651 | MCF-7 Breast | 92 / 9622 (1.0%) | 4791 / 96220 (5.0%) | −100.1 | −97.9 | 0.19 |
| FOXA1 SRX3931055 | MCF-7 Breast | 154 / 9622 (1.6%) | 5955 / 96220 (6.2%) | −99.9 | −97.8 | 0.26 |
| BRPF3 SRX796085 | RKO Digestive tract | 619 / 9622 (6.4%) | 2146 / 96220 (2.2%) | −99.9 | −97.7 | 2.88 |
| ESR1 SRX330069 | MCF-7 Breast | 99 / 9622 (1.0%) | 4926 / 96220 (5.1%) | −99.9 | −97.7 | 0.20 |
| ESR1 SRX20282954 | MCF-7 Breast | 209 / 9622 (2.2%) | 6900 / 96220 (7.2%) | −99.9 | −97.7 | 0.30 |
| JUNB SRX8488074 | SUM 229PE Breast | 257 / 9622 (2.7%) | 7686 / 96220 (8.0%) | −99.9 | −97.7 | 0.33 |
| FOXA1 SRX9604647 | LNCAP Prostate | 290 / 9622 (3.0%) | 8204 / 96220 (8.5%) | −99.8 | −97.7 | 0.35 |
| TLE3 SRX4815192 | MCF-7 Breast | 164 / 9622 (1.7%) | 6119 / 96220 (6.4%) | −99.6 | −97.4 | 0.27 |
| MEAF6 DRX234811 | 293 Kidney | 965 / 9622 (10.0%) | 4345 / 96220 (4.5%) | −99.4 | −97.2 | 2.22 |
| TET2 SRX1427029 | 293 Kidney | 777 / 9622 (8.1%) | 3115 / 96220 (3.2%) | −99.3 | −97.2 | 2.49 |
| FOXA1 SRX1787655 | MCF-7 Breast | 78 / 9622 (0.8%) | 4482 / 96220 (4.7%) | −99.2 | −97.0 | 0.17 |
| ESR1 SRX1012629 | MCF-7 Breast | 105 / 9622 (1.1%) | 5020 / 96220 (5.2%) | −99.1 | −97.0 | 0.21 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 525 / 9622 (5.5%) | 1630 / 96220 (1.7%) | −98.9 | −96.7 | 3.22 |
| AR SRX1067070 | LHSAR Prostate | 492 / 9622 (5.1%) | 11151 / 96220 (11.6%) | −98.8 | −96.7 | 0.44 |
| JUNB SRX10119383 | MCF 10A Breast | 115 / 9622 (1.2%) | 5204 / 96220 (5.4%) | −98.8 | −96.6 | 0.22 |
| EP300 SRX1012648 | MCF-7 Breast | 71 / 9622 (0.7%) | 4311 / 96220 (4.5%) | −98.5 | −96.3 | 0.16 |
| FOXA1 SRX5323843 | MCF-7 Breast | 81 / 9622 (0.8%) | 4523 / 96220 (4.7%) | −98.4 | −96.3 | 0.18 |
| MethylCap SRX014766 | NB-4 Blood | 929 / 9622 (9.7%) | 4119 / 96220 (4.3%) | −98.4 | −96.3 | 2.26 |
| STAT3 SRX150536 | MCF 10A Breast | 205 / 9622 (2.1%) | 6783 / 96220 (7.0%) | −98.4 | −96.3 | 0.30 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 170 / 9622 (1.8%) | 6186 / 96220 (6.4%) | −98.3 | −96.1 | 0.27 |
| RELA SRX2207673 | HUVEC Cardiovascular | 732 / 9622 (7.6%) | 14389 / 96220 (15.0%) | −98.1 | −96.0 | 0.51 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 174 / 9622 (1.8%) | 6250 / 96220 (6.5%) | −98.1 | −96.0 | 0.28 |
| FOXA1 SRX028635 | MCF-7 Breast | 77 / 9622 (0.8%) | 4428 / 96220 (4.6%) | −98.1 | −95.9 | 0.17 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 136 / 9622 (1.4%) | 5574 / 96220 (5.8%) | −98.0 | −95.9 | 0.24 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 637 / 9622 (6.6%) | 13114 / 96220 (13.6%) | −97.9 | −95.8 | 0.49 |
| ARID1A SRX5089379 | MCF-7 Breast | 188 / 9622 (2.0%) | 6471 / 96220 (6.7%) | −97.6 | −95.5 | 0.29 |
| ESR1 SRX10365533 | MCF-7 Breast | 76 / 9622 (0.8%) | 4392 / 96220 (4.6%) | −97.6 | −95.4 | 0.17 |
| FOXA1 SRX219284 | LNCAP Prostate | 258 / 9622 (2.7%) | 7614 / 96220 (7.9%) | −97.4 | −95.3 | 0.34 |
| ESR1 SRX20282973 | MCF-7 Breast | 234 / 9622 (2.4%) | 7227 / 96220 (7.5%) | −97.3 | −95.2 | 0.32 |
| FOXA1 SRX3923516 | MCF-7 Breast | 129 / 9622 (1.3%) | 5415 / 96220 (5.6%) | −97.2 | −95.1 | 0.24 |
| FOS SRX3322636 | MCF-7 Breast | 111 / 9622 (1.2%) | 5074 / 96220 (5.3%) | −97.0 | −94.9 | 0.22 |
| CEBPB SRX190345 | MCF-7 Breast | 135 / 9622 (1.4%) | 5514 / 96220 (5.7%) | −96.8 | −94.7 | 0.24 |
| NR3C1 SRX10976921 | A549 Lung | 122 / 9622 (1.3%) | 5273 / 96220 (5.5%) | −96.6 | −94.5 | 0.23 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 172 / 9622 (1.8%) | 6165 / 96220 (6.4%) | −96.6 | −94.5 | 0.28 |
| DAXX SRX1021630 | PC-3 Prostate | 190 / 9622 (2.0%) | 6470 / 96220 (6.7%) | −96.5 | −94.4 | 0.29 |
| FOXA1 SRX1447317 | MCF-7 Breast | 117 / 9622 (1.2%) | 5170 / 96220 (5.4%) | −96.5 | −94.4 | 0.23 |
| BRPF3 SRX796086 | RKO Digestive tract | 822 / 9622 (8.5%) | 3456 / 96220 (3.6%) | −96.4 | −94.3 | 2.38 |
| PGR SRX1012655 | MCF-7 Breast | 111 / 9622 (1.2%) | 5056 / 96220 (5.3%) | −96.4 | −94.3 | 0.22 |
| AR SRX1067069 | LHSAR Prostate | 242 / 9622 (2.5%) | 7321 / 96220 (7.6%) | −96.2 | −94.1 | 0.33 |
| FOXA1 SRX190282 | A549 Lung | 120 / 9622 (1.2%) | 5218 / 96220 (5.4%) | −96.2 | −94.1 | 0.23 |
| FOXA1 SRX190181 | A549 Lung | 127 / 9622 (1.3%) | 5350 / 96220 (5.6%) | −96.1 | −94.0 | 0.24 |
| ESR1 SRX3123829 | MCF-7 Breast | 98 / 9622 (1.0%) | 4796 / 96220 (5.0%) | −96.1 | −94.0 | 0.20 |
| ESR1 SRX2912055 | MCF-7 Breast | 56 / 9622 (0.6%) | 3921 / 96220 (4.1%) | −96.0 | −93.9 | 0.14 |
| GATA3 SRX190194 | SK-N-SH Neural | 486 / 9622 (5.1%) | 10954 / 96220 (11.4%) | −95.9 | −93.8 | 0.44 |
| PHF6 SRX11508321 | G-401 Kidney | 897 / 9622 (9.3%) | 3960 / 96220 (4.1%) | −95.8 | −93.8 | 2.27 |
| FOXA1 SRX100506 | Hep G2 Liver | 261 / 9622 (2.7%) | 7608 / 96220 (7.9%) | −95.8 | −93.8 | 0.34 |
| FOXA1 SRX9604645 | LNCAP Prostate | 277 / 9622 (2.9%) | 7864 / 96220 (8.2%) | −95.8 | −93.7 | 0.35 |
| BRD1 SRX286203 | RKO Digestive tract | 661 / 9622 (6.9%) | 2456 / 96220 (2.6%) | −95.8 | −93.7 | 2.69 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 108 / 9622 (1.1%) | 4980 / 96220 (5.2%) | −95.7 | −93.6 | 0.22 |
| ESR1 SRX2943591 | MCF-7 Breast | 126 / 9622 (1.3%) | 5314 / 96220 (5.5%) | −95.6 | −93.5 | 0.24 |
| ESR1 SRX330067 | MCF-7 Breast | 168 / 9622 (1.7%) | 6063 / 96220 (6.3%) | −95.6 | −93.5 | 0.28 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 167 / 9622 (1.7%) | 6046 / 96220 (6.3%) | −95.5 | −93.4 | 0.28 |
| YAP1 SRX10119364 | MCF 10A Breast | 153 / 9622 (1.6%) | 5787 / 96220 (6.0%) | −95.1 | −93.0 | 0.26 |
| FOXA1 SRX3931033 | MCF-7 Breast | 113 / 9622 (1.2%) | 5050 / 96220 (5.2%) | −95.0 | −92.9 | 0.22 |
| FOXA1 SRX1161203 | T-47D Breast | 129 / 9622 (1.3%) | 5343 / 96220 (5.6%) | −94.8 | −92.7 | 0.24 |
| AR SRX9469988 | LAPC-4 Prostate | 267 / 9622 (2.8%) | 7669 / 96220 (8.0%) | −94.7 | −92.7 | 0.35 |
| MYOCD SRX5598318 | A549 Lung | 998 / 9622 (10.4%) | 4669 / 96220 (4.9%) | −94.7 | −92.6 | 2.14 |
| ESR1 SRX20282955 | MCF-7 Breast | 210 / 9622 (2.2%) | 6745 / 96220 (7.0%) | −94.6 | −92.5 | 0.31 |
| ESR1 SRX1531796 | MCF-7 Breast | 92 / 9622 (1.0%) | 4633 / 96220 (4.8%) | −94.6 | −92.5 | 0.20 |
| LEO1 SRX1873456 | SEM Blood | 838 / 9622 (8.7%) | 3593 / 96220 (3.7%) | −94.5 | −92.5 | 2.33 |
| KAT7 SRX101303 | RKO Digestive tract | 750 / 9622 (7.8%) | 3027 / 96220 (3.1%) | −94.5 | −92.5 | 2.48 |
| SSRP1 SRX3436567 | HT-1080 Bone | 235 / 9622 (2.4%) | 328 / 96220 (0.3%) | −94.4 | −92.4 | 7.16 |
| FOXA1 SRX6878603 | LNCAP Prostate | 213 / 9622 (2.2%) | 6784 / 96220 (7.1%) | −94.4 | −92.3 | 0.31 |
| CHD6 SRX17709201 | C4-2 Prostate | 890 / 9622 (9.2%) | 3943 / 96220 (4.1%) | −94.4 | −92.3 | 2.26 |
| ESR1 SRX1469949 | MCF-7 Breast | 99 / 9622 (1.0%) | 4764 / 96220 (5.0%) | −94.3 | −92.2 | 0.21 |
| ESR1 SRX10365535 | MCF-7 Breast | 158 / 9622 (1.6%) | 5846 / 96220 (6.1%) | −94.1 | −92.1 | 0.27 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 306 / 9622 (3.2%) | 604 / 96220 (0.6%) | −94.0 | −92.0 | 5.07 |
| NR3C1 SRX19024866 | MCF-7 Breast | 49 / 9622 (0.5%) | 3694 / 96220 (3.8%) | −93.7 | −91.6 | 0.13 |
| JUNB SRX10119384 | MCF 10A Breast | 104 / 9622 (1.1%) | 4841 / 96220 (5.0%) | −93.6 | −91.6 | 0.21 |
| FOSL2 SRX190204 | A549 Lung | 191 / 9622 (2.0%) | 6396 / 96220 (6.6%) | −93.6 | −91.6 | 0.30 |
| SMARCA4 SRX5212362 | Mel270 Others | 355 / 9622 (3.7%) | 8968 / 96220 (9.3%) | −93.5 | −91.5 | 0.40 |
| FOXA1 SRX5203303 | MCF-7 Breast | 49 / 9622 (0.5%) | 3690 / 96220 (3.8%) | −93.5 | −91.5 | 0.13 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 291 / 9622 (3.0%) | 7996 / 96220 (8.3%) | −93.5 | −91.4 | 0.36 |
| FOXA1 SRX3923518 | MCF-7 Breast | 125 / 9622 (1.3%) | 5227 / 96220 (5.4%) | −93.4 | −91.4 | 0.24 |
| ESR1 SRX371475 | BT-474 Breast | 90 / 9622 (0.9%) | 4559 / 96220 (4.7%) | −93.4 | −91.3 | 0.20 |
| FOXA1 SRX3923517 | MCF-7 Breast | 128 / 9622 (1.3%) | 5279 / 96220 (5.5%) | −93.2 | −91.1 | 0.24 |
| PRRX1 SRX15235713 | Hs 578T Breast | 246 / 9622 (2.6%) | 7281 / 96220 (7.6%) | −93.2 | −91.1 | 0.34 |
| GATA3 SRX6712581 | MCF-7 Breast | 160 / 9622 (1.7%) | 5843 / 96220 (6.1%) | −93.0 | −91.0 | 0.27 |
| ESR1 SRX330068 | MCF-7 Breast | 77 / 9622 (0.8%) | 4279 / 96220 (4.4%) | −92.8 | −90.8 | 0.18 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 137 / 9622 (1.4%) | 5429 / 96220 (5.6%) | −92.7 | −90.7 | 0.25 |
| ATF3 SRX2207918 | CS1AN Epidermis | 1312 / 9622 (13.6%) | 6977 / 96220 (7.3%) | −92.7 | −90.7 | 1.88 |
| FOXA2 SRX100448 | Hep G2 Liver | 216 / 9622 (2.2%) | 6774 / 96220 (7.0%) | −92.5 | −90.5 | 0.32 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 494 / 9622 (5.1%) | 10928 / 96220 (11.4%) | −92.5 | −90.5 | 0.45 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 156 / 9622 (1.6%) | 5757 / 96220 (6.0%) | −92.5 | −90.4 | 0.27 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 451 / 9622 (4.7%) | 1310 / 96220 (1.4%) | −92.4 | −90.4 | 3.44 |
| ESR1 SRX20282959 | MCF-7 Breast | 67 / 9622 (0.7%) | 4059 / 96220 (4.2%) | −92.3 | −90.3 | 0.17 |
| NR3C1 SRX10977372 | A549 Lung | 100 / 9622 (1.0%) | 4723 / 96220 (4.9%) | −92.3 | −90.3 | 0.21 |
| ESR1 SRX4451213 | MCF-7 Breast | 200 / 9622 (2.1%) | 6499 / 96220 (6.8%) | −92.3 | −90.2 | 0.31 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 192 / 9622 (2.0%) | 6366 / 96220 (6.6%) | −92.2 | −90.1 | 0.30 |
| GATA3 SRX5457550 | MCF-7 Breast | 226 / 9622 (2.3%) | 6913 / 96220 (7.2%) | −91.8 | −89.8 | 0.33 |
| SMARCA4 SRX5212357 | Mel270 Others | 299 / 9622 (3.1%) | 8062 / 96220 (8.4%) | −91.8 | −89.8 | 0.37 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 435 / 9622 (4.5%) | 1234 / 96220 (1.3%) | −91.8 | −89.8 | 3.53 |
| ESR1 SRX20282938 | MCF-7 Breast | 154 / 9622 (1.6%) | 5696 / 96220 (5.9%) | −91.7 | −89.7 | 0.27 |
| ESR1 SRX20282940 | MCF-7 Breast | 222 / 9622 (2.3%) | 6841 / 96220 (7.1%) | −91.6 | −89.6 | 0.32 |
| FOXA1 SRX11222438 | MCF-7 Breast | 96 / 9622 (1.0%) | 4620 / 96220 (4.8%) | −91.5 | −89.5 | 0.21 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 126 / 9622 (1.3%) | 5181 / 96220 (5.4%) | −91.2 | −89.2 | 0.24 |
| NR2F2 SRX190293 | MCF-7 Breast | 213 / 9622 (2.2%) | 6679 / 96220 (6.9%) | −91.2 | −89.2 | 0.32 |
| TEAD1 SRX3401272 | MCF-7 Breast | 146 / 9622 (1.5%) | 5537 / 96220 (5.8%) | −91.0 | −89.0 | 0.26 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 314 / 9622 (3.3%) | 662 / 96220 (0.7%) | −90.9 | −88.9 | 4.74 |
| CDK9 SRX7366783 | MCF-7 Breast | 151 / 9622 (1.6%) | 97 / 96220 (0.1%) | −90.8 | −88.8 | 15.57 |
| FOS SRX070879 | HUVEC Cardiovascular | 209 / 9622 (2.2%) | 6602 / 96220 (6.9%) | −90.8 | −88.8 | 0.32 |
| RELA SRX2207672 | HUVEC Cardiovascular | 808 / 9622 (8.4%) | 15050 / 96220 (15.6%) | −90.7 | −88.7 | 0.54 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 395 / 9622 (4.1%) | 1043 / 96220 (1.1%) | −90.7 | −88.7 | 3.79 |
| JUN SRX17561461 | LPS141 Adipocyte | 306 / 9622 (3.2%) | 8116 / 96220 (8.4%) | −90.4 | −88.4 | 0.38 |
| ZEB1 SRX13298925 | MCF-7 Breast | 112 / 9622 (1.2%) | 4892 / 96220 (5.1%) | −90.3 | −88.3 | 0.23 |
| ESR1 SRX3110725 | MCF-7 Breast | 179 / 9622 (1.9%) | 6084 / 96220 (6.3%) | −90.3 | −88.3 | 0.29 |
| FOXA1 SRX3923519 | MCF-7 Breast | 115 / 9622 (1.2%) | 4943 / 96220 (5.1%) | −90.1 | −88.1 | 0.23 |
| FOXA1 SRX1961158 | T-47D Breast | 193 / 9622 (2.0%) | 6310 / 96220 (6.6%) | −90.0 | −88.0 | 0.31 |
| FOXA1 SRX1961157 | T-47D Breast | 215 / 9622 (2.2%) | 6673 / 96220 (6.9%) | −90.0 | −88.0 | 0.32 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 209 / 9622 (2.2%) | 6574 / 96220 (6.8%) | −90.0 | −88.0 | 0.32 |
| ESR1 SRX2943589 | MCF-7 Breast | 89 / 9622 (0.9%) | 4438 / 96220 (4.6%) | −89.9 | −87.9 | 0.20 |
| FOXA1 SRX1885184 | LNCAP Prostate | 184 / 9622 (1.9%) | 6152 / 96220 (6.4%) | −89.8 | −87.8 | 0.30 |
| FOXA2 SRX3230382 | Hep G2 Liver | 281 / 9622 (2.9%) | 7712 / 96220 (8.0%) | −89.8 | −87.8 | 0.36 |
| EP300 SRX1012644 | MCF-7 Breast | 77 / 9622 (0.8%) | 4191 / 96220 (4.4%) | −89.6 | −87.6 | 0.18 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 409 / 9622 (4.3%) | 9611 / 96220 (10.0%) | −89.6 | −87.6 | 0.43 |
| ESR1 SRX371474 | BT-474 Breast | 85 / 9622 (0.9%) | 4349 / 96220 (4.5%) | −89.6 | −87.6 | 0.20 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 900 / 9622 (9.4%) | 4110 / 96220 (4.3%) | −89.6 | −87.6 | 2.19 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 214 / 9622 (2.2%) | 6636 / 96220 (6.9%) | −89.5 | −87.5 | 0.32 |
| NR3C1 SRX17639412 | A549 Lung | 218 / 9622 (2.3%) | 6702 / 96220 (7.0%) | −89.4 | −87.4 | 0.33 |
| WWTR1 SRX10119367 | MCF 10A Breast | 240 / 9622 (2.5%) | 7053 / 96220 (7.3%) | −89.4 | −87.4 | 0.34 |
| FOXA1 SRX3931056 | MCF-7 Breast | 109 / 9622 (1.1%) | 4809 / 96220 (5.0%) | −89.4 | −87.4 | 0.23 |
| KMT2A SRX2323891 | 293 Kidney | 567 / 9622 (5.9%) | 1996 / 96220 (2.1%) | −89.2 | −87.2 | 2.84 |
| ESR1 SRX1012633 | MCF-7 Breast | 94 / 9622 (1.0%) | 4511 / 96220 (4.7%) | −89.1 | −87.1 | 0.21 |
| FOXA1 SRX6878604 | LNCAP Prostate | 157 / 9622 (1.6%) | 5665 / 96220 (5.9%) | −89.1 | −87.1 | 0.28 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 166 / 9622 (1.7%) | 5818 / 96220 (6.0%) | −89.0 | −87.0 | 0.29 |
| NFYB SRX16608147 | HeLa Uterus | 167 / 9622 (1.7%) | 142 / 96220 (0.1%) | −89.0 | −87.0 | 11.76 |
| FOSL2 SRX190296 | SK-N-SH Neural | 274 / 9622 (2.8%) | 7572 / 96220 (7.9%) | −89.0 | −87.0 | 0.36 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 91 / 9622 (0.9%) | 4447 / 96220 (4.6%) | −88.9 | −87.0 | 0.20 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 479 / 9622 (5.0%) | 10576 / 96220 (11.0%) | −88.9 | −86.9 | 0.45 |
| EP300 SRX176885 | MCF-7 Breast | 93 / 9622 (1.0%) | 4484 / 96220 (4.7%) | −88.9 | −86.9 | 0.21 |
| ESR1 SRX10365534 | MCF-7 Breast | 47 / 9622 (0.5%) | 3517 / 96220 (3.7%) | −88.8 | −86.9 | 0.13 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 292 / 9622 (3.0%) | 7844 / 96220 (8.2%) | −88.8 | −86.8 | 0.37 |
| NR3C1 SRX19024870 | MCF-7 Breast | 52 / 9622 (0.5%) | 3632 / 96220 (3.8%) | −88.8 | −86.8 | 0.14 |
| SMARCA4 SRX5212371 | Mel270 Others | 297 / 9622 (3.1%) | 7919 / 96220 (8.2%) | −88.7 | −86.8 | 0.38 |
| GRHL3 SRX2582161 | NHEK Epidermis | 532 / 9622 (5.5%) | 1801 / 96220 (1.9%) | −88.7 | −86.7 | 2.95 |
| ESR1 SRX2881000 | MCF-7 Breast | 181 / 9622 (1.9%) | 6060 / 96220 (6.3%) | −88.5 | −86.5 | 0.30 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 467 / 9622 (4.9%) | 1442 / 96220 (1.5%) | −88.5 | −86.5 | 3.24 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 598 / 9622 (6.2%) | 12191 / 96220 (12.7%) | −88.4 | −86.5 | 0.49 |
| ESR1 SRX20282953 | MCF-7 Breast | 166 / 9622 (1.7%) | 5796 / 96220 (6.0%) | −88.3 | −86.3 | 0.29 |
| RELA SRX5938177 | FaDu Others | 180 / 9622 (1.9%) | 6035 / 96220 (6.3%) | −88.2 | −86.3 | 0.30 |
| ESR1 SRX8537722 | MCF-7 Breast | 189 / 9622 (2.0%) | 6176 / 96220 (6.4%) | −88.0 | −86.1 | 0.31 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 958 / 9622 (10.0%) | 4544 / 96220 (4.7%) | −88.0 | −86.0 | 2.11 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 407 / 9622 (4.2%) | 9516 / 96220 (9.9%) | −88.0 | −86.0 | 0.43 |
| FOXA1 SRX15430999 | T-47D Breast | 232 / 9622 (2.4%) | 6875 / 96220 (7.1%) | −87.9 | −86.0 | 0.34 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 194 / 9622 (2.0%) | 6255 / 96220 (6.5%) | −87.9 | −85.9 | 0.31 |
| ARID1A SRX5089388 | MCF-7 Breast | 95 / 9622 (1.0%) | 4488 / 96220 (4.7%) | −87.6 | −85.6 | 0.21 |
| ESR1 SRX2881002 | MCF-7 Breast | 196 / 9622 (2.0%) | 6279 / 96220 (6.5%) | −87.6 | −85.6 | 0.31 |
| MEAF6 DRX300417 | 293 Kidney | 864 / 9622 (9.0%) | 3911 / 96220 (4.1%) | −87.5 | −85.5 | 2.21 |
| FOXA1 SRX1033292 | LNCAP Prostate | 95 / 9622 (1.0%) | 4479 / 96220 (4.7%) | −87.3 | −85.3 | 0.21 |
| FOXA1 SRX2017928 | LNCAP Prostate | 241 / 9622 (2.5%) | 6993 / 96220 (7.3%) | −87.2 | −85.2 | 0.34 |
| NR3C1 SRX10977373 | A549 Lung | 101 / 9622 (1.0%) | 4591 / 96220 (4.8%) | −87.2 | −85.2 | 0.22 |
| ESR1 SRX20282971 | MCF-7 Breast | 207 / 9622 (2.2%) | 6443 / 96220 (6.7%) | −87.1 | −85.1 | 0.32 |
| FOXA1 SRX1885181 | LNCAP Prostate | 181 / 9622 (1.9%) | 6010 / 96220 (6.2%) | −87.1 | −85.1 | 0.30 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 711 / 9622 (7.4%) | 2912 / 96220 (3.0%) | −87.1 | −85.1 | 2.44 |
| ESR1 SRX10365558 | MCF-7 Breast | 133 / 9622 (1.4%) | 5179 / 96220 (5.4%) | −87.1 | −85.1 | 0.26 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 131 / 9622 (1.4%) | 5142 / 96220 (5.3%) | −87.0 | −85.1 | 0.25 |
| FOXA1 SRX2642368 | VCaP Prostate | 253 / 9622 (2.6%) | 7178 / 96220 (7.5%) | −87.0 | −85.1 | 0.35 |
| SUZ12 SRX10184494 | K-562 Blood | 1413 / 9622 (14.7%) | 7904 / 96220 (8.2%) | −86.9 | −85.0 | 1.79 |
| NR3C1 SRX10977357 | A549 Lung | 118 / 9622 (1.2%) | 4890 / 96220 (5.1%) | −86.6 | −84.6 | 0.24 |
| FOXA1 SRX3931032 | MCF-7 Breast | 113 / 9622 (1.2%) | 4794 / 96220 (5.0%) | −86.5 | −84.5 | 0.24 |
| ESR1 SRX1012630 | MCF-7 Breast | 67 / 9622 (0.7%) | 3892 / 96220 (4.0%) | −86.5 | −84.5 | 0.17 |
| FOXA1 SRX142908 | LNCAP Prostate | 97 / 9622 (1.0%) | 4488 / 96220 (4.7%) | −86.3 | −84.4 | 0.22 |
| EP300 SRX2194265 | SUM 159PT Breast | 334 / 9622 (3.5%) | 8386 / 96220 (8.7%) | −86.3 | −84.4 | 0.40 |
| Epitope tags SRX8080558 | Mammary gland adenocarcinoma Breast | 66 / 9622 (0.7%) | 3861 / 96220 (4.0%) | −86.1 | −84.2 | 0.17 |
| FOXA1 SRX667985 | VCaP Prostate | 155 / 9622 (1.6%) | 5535 / 96220 (5.8%) | −86.1 | −84.2 | 0.28 |
| ARID1A SRX5089385 | MCF-7 Breast | 151 / 9622 (1.6%) | 5464 / 96220 (5.7%) | −86.0 | −84.1 | 0.28 |
| FOXA1 SRX3923515 | MCF-7 Breast | 108 / 9622 (1.1%) | 4687 / 96220 (4.9%) | −86.0 | −84.0 | 0.23 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 133 / 9622 (1.4%) | 5141 / 96220 (5.3%) | −85.9 | −84.0 | 0.26 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 130 / 9622 (1.4%) | 5082 / 96220 (5.3%) | −85.6 | −83.7 | 0.26 |
| ARID1A SRX5089391 | MCF-7 Breast | 110 / 9622 (1.1%) | 4708 / 96220 (4.9%) | −85.5 | −83.6 | 0.23 |
| EP300 SRX1012643 | MCF-7 Breast | 64 / 9622 (0.7%) | 3800 / 96220 (3.9%) | −85.5 | −83.6 | 0.17 |
| FOXA1 SRX5203307 | MCF-7 Breast | 46 / 9622 (0.5%) | 3406 / 96220 (3.5%) | −85.4 | −83.5 | 0.14 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 112 / 9622 (1.2%) | 4742 / 96220 (4.9%) | −85.3 | −83.4 | 0.24 |
| FOXA1 SRX497612 | VCaP Prostate | 195 / 9622 (2.0%) | 6188 / 96220 (6.4%) | −85.3 | −83.4 | 0.32 |
| FOXA1 SRX9604646 | LNCAP Prostate | 288 / 9622 (3.0%) | 7650 / 96220 (8.0%) | −85.1 | −83.2 | 0.38 |
| FOXA1 SRX5203294 | MCF-7 Breast | 46 / 9622 (0.5%) | 3389 / 96220 (3.5%) | −84.9 | −83.0 | 0.14 |
| FOS SRX3322637 | MCF-7 Breast | 104 / 9622 (1.1%) | 4579 / 96220 (4.8%) | −84.9 | −83.0 | 0.23 |
| FOXA1 SRX6860635 | T-47D Breast | 156 / 9622 (1.6%) | 5515 / 96220 (5.7%) | −84.9 | −83.0 | 0.28 |
| FOXA1 SRX1447316 | MCF-7 Breast | 79 / 9622 (0.8%) | 4094 / 96220 (4.3%) | −84.8 | −82.9 | 0.19 |
| FOXA1 SRX5323829 | T-47D Breast | 111 / 9622 (1.2%) | 4709 / 96220 (4.9%) | −84.8 | −82.9 | 0.24 |
| FOS SRX150664 | HUVEC Cardiovascular | 280 / 9622 (2.9%) | 7513 / 96220 (7.8%) | −84.8 | −82.8 | 0.37 |
| ESR1 SRX2513520 | MCF-7 Breast | 123 / 9622 (1.3%) | 4925 / 96220 (5.1%) | −84.7 | −82.8 | 0.25 |
| ESR1 SRX4451212 | MCF-7 Breast | 196 / 9622 (2.0%) | 6182 / 96220 (6.4%) | −84.6 | −82.7 | 0.32 |
| FOXA1 SRX2017929 | LNCAP Prostate | 280 / 9622 (2.9%) | 7506 / 96220 (7.8%) | −84.5 | −82.6 | 0.37 |
| FOXA1 SRX497613 | VCaP Prostate | 144 / 9622 (1.5%) | 5286 / 96220 (5.5%) | −84.3 | −82.4 | 0.27 |
| ESR1 SRX792933 | LY2 Breast | 169 / 9622 (1.8%) | 5712 / 96220 (5.9%) | −84.2 | −82.3 | 0.30 |
| FOXA1 SRX219285 | LNCAP Prostate | 193 / 9622 (2.0%) | 6114 / 96220 (6.4%) | −84.1 | −82.2 | 0.32 |
| JUNB SRX10119385 | MCF 10A Breast | 84 / 9622 (0.9%) | 4168 / 96220 (4.3%) | −84.1 | −82.2 | 0.20 |
| NR3C1 SRX18884271 | A549 Lung | 103 / 9622 (1.1%) | 4537 / 96220 (4.7%) | −84.1 | −82.2 | 0.23 |
| TET2 SRX2513053 | Jurkat Blood | 1176 / 9622 (12.2%) | 6204 / 96220 (6.4%) | −84.1 | −82.2 | 1.90 |
| BMI1 SRX644729 | 293 Kidney | 140 / 9622 (1.5%) | 91 / 96220 (0.1%) | −83.9 | −82.0 | 15.38 |
| SFPQ SRX593748 | MCF-7 Breast | 1593 / 9622 (16.6%) | 9403 / 96220 (9.8%) | −83.9 | −82.0 | 1.69 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1066 / 9622 (11.1%) | 5408 / 96220 (5.6%) | −83.8 | −81.9 | 1.97 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 203 / 9622 (2.1%) | 6263 / 96220 (6.5%) | −83.7 | −81.8 | 0.32 |
| FOXA1 SRX1161205 | T-47D Breast | 103 / 9622 (1.1%) | 4524 / 96220 (4.7%) | −83.7 | −81.8 | 0.23 |
| EP300 SRX10976625 | A549 Lung | 117 / 9622 (1.2%) | 4783 / 96220 (5.0%) | −83.6 | −81.7 | 0.24 |
| FOXA1 SRX1787654 | MCF-7 Breast | 66 / 9622 (0.7%) | 3788 / 96220 (3.9%) | −83.6 | −81.7 | 0.17 |
| NABP2 SRX9523535 | HT-1080 Bone | 782 / 9622 (8.1%) | 3439 / 96220 (3.6%) | −83.6 | −81.7 | 2.27 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 284 / 9622 (3.0%) | 7529 / 96220 (7.8%) | −83.5 | −81.6 | 0.38 |
| ESR1 SRX1161186 | ZR-75-1 Breast | 57 / 9622 (0.6%) | 3594 / 96220 (3.7%) | −83.4 | −81.5 | 0.16 |
| FOXL2 SRX6957431 | KGN Gonad | 497 / 9622 (5.2%) | 10600 / 96220 (11.0%) | −83.4 | −81.5 | 0.47 |
| FOXA1 SRX3923511 | MCF-7 Breast | 70 / 9622 (0.7%) | 3866 / 96220 (4.0%) | −83.3 | −81.5 | 0.18 |
| ESR1 SRX8537723 | MCF-7 Breast | 168 / 9622 (1.7%) | 5658 / 96220 (5.9%) | −82.9 | −81.0 | 0.30 |
| JUN SRX2355072 | HAEC Cardiovascular | 283 / 9622 (2.9%) | 7489 / 96220 (7.8%) | −82.8 | −80.9 | 0.38 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 694 / 9622 (7.2%) | 2882 / 96220 (3.0%) | −82.8 | −80.9 | 2.41 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 141 / 9622 (1.5%) | 5185 / 96220 (5.4%) | −82.7 | −80.8 | 0.27 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 123 / 9622 (1.3%) | 58 / 96220 (0.1%) | −82.6 | −80.8 | 21.21 |
| STAT3 SRX2020842 | HCC70 Breast | 390 / 9622 (4.1%) | 9067 / 96220 (9.4%) | −82.6 | −80.7 | 0.43 |
| ESR1 SRX1469951 | MCF-7 Breast | 105 / 9622 (1.1%) | 4526 / 96220 (4.7%) | −82.6 | −80.7 | 0.23 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 614 / 9622 (6.4%) | 2383 / 96220 (2.5%) | −82.6 | −80.7 | 2.58 |
| ING5 SRX286202 | RKO Digestive tract | 714 / 9622 (7.4%) | 3018 / 96220 (3.1%) | −82.5 | −80.6 | 2.37 |
| KDM6A SRX15826236 | MCF-7 Breast | 55 / 9622 (0.6%) | 3517 / 96220 (3.7%) | −82.3 | −80.4 | 0.16 |
| FOXA1 SRX5323845 | MCF-7 Breast | 67 / 9622 (0.7%) | 3769 / 96220 (3.9%) | −82.2 | −80.3 | 0.18 |
| ESR1 SRX176856 | MCF-7 Breast | 62 / 9622 (0.6%) | 3660 / 96220 (3.8%) | −82.0 | −80.1 | 0.17 |
| WWTR1 SRX10119378 | MCF 10A Breast | 237 / 9622 (2.5%) | 6748 / 96220 (7.0%) | −81.9 | −80.0 | 0.35 |
| FOXA1 SRX1885182 | LNCAP Prostate | 179 / 9622 (1.9%) | 5809 / 96220 (6.0%) | −81.9 | −80.0 | 0.31 |
| SMARCA4 SRX5982340 | A549 Lung | 75 / 9622 (0.8%) | 3921 / 96220 (4.1%) | −81.8 | −79.9 | 0.19 |
| CEBPB SRX2194249 | SUM 159PT Breast | 209 / 9622 (2.2%) | 6291 / 96220 (6.5%) | −81.7 | −79.8 | 0.33 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 135 / 9622 (1.4%) | 5043 / 96220 (5.2%) | −81.7 | −79.8 | 0.27 |
| ESR1 SRX2513521 | MCF-7 Breast | 93 / 9622 (1.0%) | 4273 / 96220 (4.4%) | −81.7 | −79.8 | 0.22 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 157 / 9622 (1.6%) | 5427 / 96220 (5.6%) | −81.6 | −79.7 | 0.29 |
| EP300 SRX10976215 | A549 Lung | 197 / 9622 (2.0%) | 6094 / 96220 (6.3%) | −81.6 | −79.7 | 0.32 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 384 / 9622 (4.0%) | 8931 / 96220 (9.3%) | −81.5 | −79.6 | 0.43 |
| ESR1 SRX5323873 | MCF-7 Breast | 272 / 9622 (2.8%) | 7273 / 96220 (7.6%) | −81.4 | −79.5 | 0.37 |
| ESR1 SRX3110723 | MCF-7 Breast | 113 / 9622 (1.2%) | 4641 / 96220 (4.8%) | −81.4 | −79.5 | 0.24 |
| CEBPA SRX2630241 | Hep G2 Liver | 267 / 9622 (2.8%) | 7192 / 96220 (7.5%) | −81.4 | −79.5 | 0.37 |
| ZFX SRX7805370 | 293 Kidney | 647 / 9622 (6.7%) | 2611 / 96220 (2.7%) | −81.3 | −79.4 | 2.48 |
| NKX2-1 SRX2164786 | A549 Lung | 367 / 9622 (3.8%) | 8678 / 96220 (9.0%) | −81.2 | −79.4 | 0.42 |
| FOXA1 SRX1161207 | T-47D Breast | 79 / 9622 (0.8%) | 3979 / 96220 (4.1%) | −81.0 | −79.1 | 0.20 |
| GATA3 SRX11149846 | MDA-MB-453 Breast | 251 / 9622 (2.6%) | 6928 / 96220 (7.2%) | −80.9 | −79.0 | 0.36 |
| GATA3 SRX15946407 | MDA-MB-453 Breast | 251 / 9622 (2.6%) | 6928 / 96220 (7.2%) | −80.9 | −79.0 | 0.36 |
| CDK9 SRX7366781 | MCF-7 Breast | 138 / 9622 (1.4%) | 95 / 96220 (0.1%) | −80.8 | −79.0 | 14.53 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 410 / 9622 (4.3%) | 9278 / 96220 (9.6%) | −80.8 | −78.9 | 0.44 |
| NR3C1 SRX10977364 | A549 Lung | 88 / 9622 (0.9%) | 4151 / 96220 (4.3%) | −80.8 | −78.9 | 0.21 |
| AR SRX15946405 | MDA-MB-453 Breast | 133 / 9622 (1.4%) | 4980 / 96220 (5.2%) | −80.8 | −78.9 | 0.27 |
| FOXA1 SRX100477 | Hep G2 Liver | 250 / 9622 (2.6%) | 6906 / 96220 (7.2%) | −80.7 | −78.9 | 0.36 |
| NR3C1 SRX10976392 | A549 Lung | 89 / 9622 (0.9%) | 4168 / 96220 (4.3%) | −80.7 | −78.8 | 0.21 |
| Epitope tags SRX4892334 | 293 Kidney | 1312 / 9622 (13.6%) | 7324 / 96220 (7.6%) | −80.6 | −78.8 | 1.79 |
| TRPS1 SRX3401273 | MCF-7 Breast | 63 / 9622 (0.7%) | 3640 / 96220 (3.8%) | −80.6 | −78.7 | 0.17 |
| FOXA1 SRX1885185 | LNCAP Prostate | 160 / 9622 (1.7%) | 5434 / 96220 (5.6%) | −80.4 | −78.5 | 0.29 |
| FOXA1 SRX1885188 | LNCAP Prostate | 165 / 9622 (1.7%) | 5518 / 96220 (5.7%) | −80.3 | −78.5 | 0.30 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 210 / 9622 (2.2%) | 6260 / 96220 (6.5%) | −80.3 | −78.5 | 0.34 |
| AR SRX11149848 | MDA-MB-453 Breast | 134 / 9622 (1.4%) | 4981 / 96220 (5.2%) | −80.3 | −78.4 | 0.27 |
| ESR1 SRX1012628 | MCF-7 Breast | 107 / 9622 (1.1%) | 4490 / 96220 (4.7%) | −80.2 | −78.3 | 0.24 |
| Epitope tags SRX3657345 | 293 Kidney | 1308 / 9622 (13.6%) | 7308 / 96220 (7.6%) | −80.1 | −78.3 | 1.79 |
| ZEB1 SRX13298923 | MCF-7 Breast | 83 / 9622 (0.9%) | 4031 / 96220 (4.2%) | −80.1 | −78.2 | 0.21 |
| ZEB1 SRX13298924 | MCF-7 Breast | 98 / 9622 (1.0%) | 4320 / 96220 (4.5%) | −80.0 | −78.2 | 0.23 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 90 / 9622 (0.9%) | 4165 / 96220 (4.3%) | −80.0 | −78.1 | 0.22 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 224 / 9622 (2.3%) | 6466 / 96220 (6.7%) | −79.8 | −78.0 | 0.35 |
| ARID1A SRX5679787 | 12Z Others | 79 / 9622 (0.8%) | 3943 / 96220 (4.1%) | −79.7 | −77.9 | 0.20 |
| FOXA1 SRX2642369 | VCaP Prostate | 196 / 9622 (2.0%) | 6012 / 96220 (6.2%) | −79.7 | −77.8 | 0.33 |
| EP300 SRX2671813 | Fibroblasts Others | 190 / 9622 (2.0%) | 5912 / 96220 (6.1%) | −79.6 | −77.8 | 0.32 |
| GATA2 SRX16314543 | Trophoblast stem cells Placenta | 194 / 9622 (2.0%) | 5975 / 96220 (6.2%) | −79.6 | −77.7 | 0.32 |
| MAU2 SRX11120893 | MCF-7 Breast | 82 / 9622 (0.9%) | 3993 / 96220 (4.1%) | −79.4 | −77.6 | 0.21 |
| FOXA1 SRX5323830 | T-47D Breast | 125 / 9622 (1.3%) | 4787 / 96220 (5.0%) | −79.2 | −77.3 | 0.26 |
| FOXA1 SRX3931073 | MCF-7 Breast | 123 / 9622 (1.3%) | 4751 / 96220 (4.9%) | −79.1 | −77.3 | 0.26 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 170 / 9622 (1.8%) | 188 / 96220 (0.2%) | −79.0 | −77.2 | 9.04 |
| EP300 SRX176883 | MCF-7 Breast | 94 / 9622 (1.0%) | 4213 / 96220 (4.4%) | −79.0 | −77.2 | 0.22 |
| NR3C1 SRX1161181 | ZR-75-1 Breast | 53 / 9622 (0.6%) | 3381 / 96220 (3.5%) | −79.0 | −77.1 | 0.16 |
| NR3C1 SRX1161167 | MCF-7 Breast | 45 / 9622 (0.5%) | 3207 / 96220 (3.3%) | −78.9 | −77.1 | 0.14 |
| CEBPB SRX2194250 | SUM 159PT Breast | 270 / 9622 (2.8%) | 7149 / 96220 (7.4%) | −78.9 | −77.1 | 0.38 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 1026 / 9622 (10.7%) | 5245 / 96220 (5.5%) | −78.9 | −77.1 | 1.96 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 304 / 9622 (3.2%) | 7659 / 96220 (8.0%) | −78.9 | −77.0 | 0.40 |
| TEAD1 SRX716558 | SF268 Neural | 108 / 9622 (1.1%) | 4468 / 96220 (4.6%) | −78.8 | −76.9 | 0.24 |
| FOXA1 SRX1961163 | T-47D Breast | 137 / 9622 (1.4%) | 4986 / 96220 (5.2%) | −78.7 | −76.9 | 0.27 |
| FOXA1 SRX2642365 | VCaP Prostate | 205 / 9622 (2.1%) | 6119 / 96220 (6.4%) | −78.6 | −76.8 | 0.34 |
| FOXA1 SRX1885187 | LNCAP Prostate | 130 / 9622 (1.4%) | 4858 / 96220 (5.0%) | −78.6 | −76.8 | 0.27 |
| ESR1 SRX3110720 | MCF-7 Breast | 86 / 9622 (0.9%) | 4045 / 96220 (4.2%) | −78.5 | −76.7 | 0.21 |
| ESR1 SRX2513517 | MCF-7 Breast | 146 / 9622 (1.5%) | 5134 / 96220 (5.3%) | −78.4 | −76.6 | 0.28 |
| FOXA1 SRX667984 | VCaP Prostate | 140 / 9622 (1.5%) | 5028 / 96220 (5.2%) | −78.4 | −76.6 | 0.28 |
| FOXA1 SRX667987 | VCaP Prostate | 165 / 9622 (1.7%) | 5448 / 96220 (5.7%) | −78.2 | −76.4 | 0.30 |
| EP300 SRX717860 | HeLa Uterus | 141 / 9622 (1.5%) | 5041 / 96220 (5.2%) | −78.2 | −76.4 | 0.28 |
| Epitope tags SRX10549778 | K-562 Blood | 610 / 9622 (6.3%) | 2434 / 96220 (2.5%) | −78.0 | −76.2 | 2.51 |
Showing first 500 of 15075 rows.